A detailed history of Bahl & Gaynor Inc transactions in Clorox CO stock. As of the latest transaction made, Bahl & Gaynor Inc holds 10,794 shares of CLX stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,794
Previous 13,406 19.48%
Holding current value
$1.83 Million
Previous $1.83 Million 3.88%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$131.73 - $166.97 $344,078 - $436,125
-2,612 Reduced 19.48%
10,794 $1.76 Million
Q2 2024

Aug 07, 2024

SELL
$128.21 - $151.65 $392,963 - $464,807
-3,065 Reduced 18.61%
13,406 $1.83 Million
Q1 2024

May 10, 2024

SELL
$139.73 - $157.03 $21,378 - $24,025
-153 Reduced 0.92%
16,471 $2.52 Million
Q4 2023

Feb 02, 2024

SELL
$115.38 - $145.63 $32,075 - $40,485
-278 Reduced 1.64%
16,624 $2.37 Million
Q3 2023

Nov 03, 2023

BUY
$128.62 - $166.13 $31,640 - $40,867
246 Added 1.48%
16,902 $2.22 Million
Q2 2023

Aug 14, 2023

SELL
$153.94 - $175.61 $9,698 - $11,063
-63 Reduced 0.38%
16,656 $2.65 Million
Q1 2023

May 03, 2023

SELL
$139.79 - $158.24 $9,505 - $10,760
-68 Reduced 0.41%
16,719 $2.65 Million
Q4 2022

Feb 10, 2023

BUY
$125.76 - $150.99 $113,561 - $136,343
903 Added 5.68%
16,787 $2.36 Million
Q3 2022

Nov 14, 2022

SELL
$128.39 - $149.74 $89,872 - $104,818
-700 Reduced 4.22%
15,884 $2.04 Million
Q2 2022

Aug 08, 2022

SELL
$122.57 - $158.28 $251,513 - $324,790
-2,052 Reduced 11.01%
16,584 $2.34 Million
Q1 2022

May 12, 2022

SELL
$127.62 - $186.6 $204,192 - $298,560
-1,600 Reduced 7.91%
18,636 $2.59 Million
Q3 2021

Nov 15, 2021

SELL
$162.19 - $187.74 $243,285 - $281,610
-1,500 Reduced 6.9%
20,236 $3.35 Million
Q1 2021

May 11, 2021

SELL
$178.17 - $222.18 $89,085 - $111,090
-500 Reduced 2.25%
21,736 $4.19 Million
Q4 2020

Feb 02, 2021

SELL
$194.91 - $221.17 $2,923 - $3,317
-15 Reduced 0.07%
22,236 $4.49 Million
Q1 2020

May 26, 2020

BUY
$151.52 - $197.88 $3.37 Million - $4.4 Million
22,251 New
22,251 $3.86 Million
Q1 2020

May 15, 2020

SELL
$151.52 - $197.88 $3.6 Million - $4.7 Million
-23,751 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$145.02 - $153.54 $179,824 - $190,389
-1,240 Reduced 4.96%
23,751 $3.65 Million
Q2 2019

Aug 12, 2019

SELL
$146.72 - $159.73 $29,344 - $31,945
-200 Reduced 0.79%
24,991 $3.83 Million
Q2 2018

Aug 14, 2018

SELL
$114.8 - $135.25 $3,444 - $4,057
-30 Reduced 0.12%
25,191 $3.41 Million
Q1 2018

May 11, 2018

SELL
$124.22 - $146.44 $241,607 - $284,825
-1,945 Reduced 7.16%
25,221 $3.36 Million
Q4 2017

Feb 13, 2018

SELL
$125.32 - $149.69 $49,501 - $59,127
-395 Reduced 1.43%
27,166 $4.04 Million
Q3 2017

Nov 13, 2017

SELL
$129.33 - $139.04 $22,632 - $24,332
-175 Reduced 0.63%
27,561 $3.64 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-1,043 Reduced 3.62%
27,736 $3.7 Million
Q2 2017

Aug 10, 2017

BUY
N/A
28,779
28,779 $3.45 Million

Others Institutions Holding CLX

About CLOROX CO


  • Ticker CLX
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 123,356,000
  • Market Cap $20.9B
  • Description
  • The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-S...
More about CLX
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.